Coronavirus Vaccine: Moderna Boasts 94.5% Effectiveness In Trials

Massachusetts Based Biotech Company Moderna Receives FDA Approval To Continue Coronavirus Vaccine Trials

Pharmaceutical company Moderna shared big news this morning about its vaccine trial.

In another potential breakthrough in the fight against COVID-19, a vaccine being developed by the company showed a 94.5 percent effectiveness in its latest trial involving 30,000 participants and could be rolled out as early as next month if the FDA approves it.

The hopeful news comes a week after the announcement from Pfizer that its vaccine has a 90 percent efficacy. Experts, including Dr. Anthony Fauci, expect vaccines to be available for people in high-risk categories as early as late December.

(USA Today)

Getty Images

Sponsored Content

Sponsored Content